# InHandPlus

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/inhandplus

- Industry: Healthcare IT
- Headquarters: Pohang-si, South Korea
- Website: www.inhandplus.com
- Total disclosed funding: $2.3M
- Latest round: Series A (Jul 7, 2023)
- Investors on record: 6

## About

Based in Gyeongsangbuk-do, South Korea, and founded in 2019, InHandPlus Inc. develops personalised medication management and remote patient monitoring systems based on artificial intelligence (AI) smartwatches to generate real-world evidence and data, including medication history data, symptoms, and adverse events, from the participants to increase adherence. In July 2023, InHandPlus Inc. raised KRW 3 billion in series A funding from investors Muirwoods Ventures, MEDIC&C, Maple Investment Partners, GENAXIS Ventures, and IPS Ventures. As of July 2023, the company is led by CEO Lee Hwi-won.


InHand Plus offers an AI- and smartwatch-based medication management solution that monitors the medication. The smartwatch automatically analyses pills, injections, ointments, eye drops, inhalers, blood glucose monitors, and specific foods. The technique uses a self-developed AI smartwatch to assess what actions the user performs and when. It primarily examines when and what medication is taken to provide consumers with individualised medication management services. In addition, the business offers a Digital Healthcare Platform that connects to a proprietary smartwatch, app, and website to provide data-driven healthcare information and real-time communication capabilities, enhancing patient involvement. The platform features include a medication alarm and Message, Adverse events and symptoms, step count, heart rate, and fall-down Detection.

## Funding rounds

- Series A, Jul 7, 2023, $2.3M — Strong Ventures, Maple Investment Partners, Muirwoods Ventures, IPS Ventures, Genaxis, MediC&C Co., Ltd.

## Investors

- Strong Ventures (https://capitalatlas.ai/funds/strong-ventures) — Series A
- Maple Investment Partners (https://capitalatlas.ai/funds/maple-investment-partners) — Series A
- Muirwoods Ventures (https://capitalatlas.ai/funds/muirwoods-ventures) — Series A
- IPS Ventures (https://capitalatlas.ai/funds/ips-ventures) — Series A
- Genaxis (https://capitalatlas.ai/funds/genaxis) — Series A
- MediC&C Co., Ltd. — Series A